TELMA MCT 25/12.5 (Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg))
-13%

TELMA MCT 25/12.5 (Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg))

Original price was: ₹161.70.Current price is: ₹140.00.

TELMA MCT 25/12.5 (Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg))

Original price was: ₹161.70.Current price is: ₹140.00.

Add to cart
Buy Now
Category: Tag:

TELMA MCT 25/12.5 TAB is a combination medication commonly used to help manage high blood pressure. By maintaining healthy blood pressure levels, it aims to reduce the risk of complications related to heart and blood vessel health. This can be especially important for individuals looking to manage their cardiovascular well-being effectively.

The product contains three active ingredients: Chlorthalidone, Metoprolol Succinate, and Telmisartan. Chlorthalidone is a diuretic that helps reduce excess fluid in the body, while Metoprolol Succinate is a beta-blocker that helps relax blood vessels and lower heart rate. Telmisartan is an angiotensin receptor blocker that also aids in relaxing blood vessels. Together, these ingredients work to support optimal blood pressure control.

For best results, it is advisable to take this medication consistently as directed by a healthcare professional. Store the tablets in a cool, dry place, away from direct sunlight and moisture. It’s important to inform your doctor about any other medications you are taking to avoid potential interactions.

Some common, mild side effects may include dizziness, fatigue, or a mild headache. While these effects are typically not serious, if they persist or worsen, it is advisable to seek medical attention.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.

Reviews

There are no reviews yet.

Be the first to review “TELMA MCT 25/12.5 (Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg))”

Your email address will not be published. Required fields are marked *

Top